排序方式： 共有42条查询结果，搜索用时 234 毫秒
1.
A captive reticulated giraffe was observed constantly for three weeks prior to, and periodically for 90 days subsequent to, the birth of her calf. Extensive observations were made of the birth sequence, feeding, drinking, sleeping and one instance of an infant distress call, as well as observations of the initiation of maternal behaviour (including licking, nursing, placentophagia, and what appeared to be helping the calf to stand, guiding the calf's movements, and attempts to respond to the calf's distress call). 相似文献
2.
Y. Chen Y. Inbar S. Zilkah A. Koren M. Dinar M. Gokkes M. Raviv R. Reuveni Shlomot Medina Y. Shamir Orna Etzion Orna Duvdevani Y. Shor R. Schayer Ester Hadar Ruhama Berliner A. Gamliel J. Katan G. Kritzman Leah Tsror A. Nachmias V. Weitsman D. Mor Y. Inbar M. J. Boehm H. A. J. Hoitink Y. Hadar Y. Elad H. Yunis H. Volpin E. Pressman A. Gamliel J. Katan M. Sachs 《Phytoparasitica》1991,19(2):161-170
3.
Miriam Altstein Orna Ben-Aziz Irit Schefler Irina Zeltser Chaim Gilon 《Crop Protection》2000,19(8-10):547-555
The development of a new approach for the generation of a novel type of putative insect control agents based on backbone cyclic peptidomimetic antagonists of insect-neuropeptides is reported. The approach, termed the backbone cyclic neuropetide based on autogonist (BBC-NBA) was applied to the insect pyrokinin/pheromone biosynthesis activating neuropeptide (PBAN) family as a model, and led to the discovery of a potent linear lead antagonist and several highly potent, metabolically stable BBC peptidomimetic antagonists, devoid of agonistic activity, which inhibited in vivo PBAN-mediated activities in moths. 相似文献
4.
5.
Rassnick KM Moore AS Northrup NC Kristal O Beaulieu BB Lewis LD Page RL 《American journal of veterinary research》2006,67(3):510-516
OBJECTIVE: To determine the maximally tolerated dose (MTD) and dose-limiting toxicosis (DLT) of ifosfamide in tumor-bearing cats. ANIMALS: 38 cats with resected, recurrent, or metastatic sarcomas. PROCEDURE: The starting dosage of ifosfamide was 400 mg/m(2) of body surface area, IV, and dosages were increased by 50 to 100 mg/m(2) in cohorts of 3 cats. To protect against urotoxicosis, mesna was administered at a dosage equal to 20% of the calculated ifosfamide dosage. Diuresis with saline (0.9% NaCl) solution before and after administration of ifosfamide was used to minimize nephrotoxicosis. Samples for pharmacokinetic analysis were obtained after the MTD was reached. RESULTS: 38 cats were entered into this phase I study and were administered a single dose of ifosfamide at various dosages. The MTD was 1,000 mg/m(2), and neutropenia was the DLT. Seven of 8 episodes of neutropenia were on day 7 after treatment, and 1 cat developed severe neutropenia on day 5. Adverse effects on the gastrointestinal tract were generally mild and self-limiting, the most common of which was nausea during ifosfamide infusion. One cat had signs consistent with a drug-induced hypersensitivity reaction. There were no episodes of hemorrhagic cystitis or nephrotoxicosis. Correlations between pharmacokinetic variables and ifosfamide-associated toxicoses were not found. Preliminary evidence of antitumor activity was observed in 6 of 27 cats with measurable tumors. CONCLUSIONS AND CLINICAL RELEVANCE: The dosage of ifosfamide recommended to treat tumor-bearing cats is 900 mg/m(2) every 3 weeks. This dosage should be used in phase II clinical trials. 相似文献
6.
D.B. Bailey K.M. Rassnick O. Kristal J.D. Chretin C.E. Balkman 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2008,22(6):1397-1402
Background: Vinblastine (VBL) is commonly used in dogs at a dosage of 2.0 mg/m2. The minimal toxicity observed at this dosage indicates that higher dosages might be well tolerated. Hypothesis: The maximum tolerated dosage (MTD) for a single VBL treatment is higher than the previously published dosage of 2.0 mg/m2. Animals: Twenty‐three dogs with lymphoma or cutaneous mast cell tumors. Methods: Dogs received 1 single‐agent VBL treatment IV. The starting dosage was 3.0 mg/m2, and dosages were increased in increments of 0.5 mg/m2 in cohorts of 3 dogs. Hematologic toxicity was assessed with weekly CBCs. Gastrointestinal toxicity was assessed from medical histories from owners. Once the MTD was determined, additional dogs were treated with VBL at that dosage. Dogs whose cancers responded to VBL continued to receive treatments q2–3 weeks. Results: VBL dosages ranged from 3.0 to 4.0 mg/m2. Neutropenia was the dose‐limiting toxicity, with the nadir identified 7 days after treatment and resolving by 14 days after treatment. The MTD was 3.5 mg/m2. Sixteen dogs were treated at this dosage, and 3 experienced severe toxicity characterized by asymptomatic grade 4 neutropenia, febrile grade 4 neutropenia, and death. Gastrointestinal toxicity was mild and self‐limiting. Preliminary evidence of antitumor activity was identified in 2 of 12 dogs with lymphoma treated at the MTD. Conclusions and Clinical Importance: In dogs, single‐agent VBL is well tolerated at a dosage of 3.5 mg/m2 IV. At this dosage, the minimum safe treatment interval is q2 weeks, and adjunct treatment with prophylactic antibiotics should be considered. 相似文献
7.
Rassnick KM Williams LE Kristal O Al-Sarraf R Baez JL Zwahlen CH Dank G 《Journal of the American Veterinary Medical Association》2008,232(8):1200-1205
OBJECTIVE: To determine clinical activity and toxic effects of lomustine when used to treat cats with mast cell tumors (MCTs). DESIGN: Retrospective case series. ANIMALS: 38 cats with measurable, histologically or cytologically confirmed MCTs treated with lomustine at a dosage > or = 50 mg/m(2). PROCEDURES: Medical records were reviewed to determine response to treatment and evidence of drug toxicoses. The Kaplan-Meier method was used to estimate remission duration. RESULTS: 26 cats had cutaneous MCTs, 7 had MCTs of the mesenteric lymph nodes, 2 had gastrointestinal tract MCTs, 2 had hepatic MCTs, and 1 had MCTs involving multiple organs. Targeted lomustine dosage was 50 mg/m(2) in 22 cats and 60 mg/m(2) in 16 cats. Median administered dosage of lomustine was 56 mg/m(2) (range, 48 to 65 mg/m(2)), and median number of doses administered was 2 (range, 1 to 12). Seven cats had a complete response and 12 had a partial response, for an overall response rate of 50%. Median response duration was 168 days (range, 25 to 727 days). The most common toxicoses were neutropenia and thrombocytopenia. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that lomustine had activity against MCTs in cats and was well tolerated. Further, findings suggested that treatment with lomustine should be considered for cats with MCTs for which local treatment is not an option. 相似文献
8.
Plant screening assays were used to determine whether significant levels of growth inhibitory and phytotoxic contaminants were present in a new industrial source of potassium dihydrogen phosphate fertilizer intended for foliar and root application. Maize (Zea mays L.) plants hydroponically cultured in a controlled environment chamber, were used for the assays. The threshold concentration of industrial potassium phosphate which just caused burn damage symptoms, when applied as standard droplets to the leaf surface with Tween 80 wetting agent was 0.5M. The comparative threshold concentration for damage by an ultrapure analytical grade of potassium phosphate was >0.6M. Thus, the industrial grade had slightly higher toxicity for leaf application. Effects on plants of supplying industrial and analytical grade phosphates via the roots were also compared. Root and leaf elongation kinetics, mature leaf cell lengths, apparent capacity for leaf cell production, shoot ontogeny, and shoot fresh weight yields were determined at low and high potassium phosphate concentrations. The effects of analytical and industrial grade fertilizer salts were equivalent. We suggest that these rapid and relatively simple plant screening assays can provide a useful safety check, prior to large scale field trails, for fertilizer nutrients produced by new industrial processes. 相似文献
9.
Moore AS Nelson RW Henry CJ Rassnick KM Kristal O Ogilvie GK Kintzer P 《Journal of the American Veterinary Medical Association》2002,221(6):811-818
OBJECTIVE: To determine toxic effects of streptozocin given in combination with a diuresis protocol in dogs and establish whether streptozocin is efficacious in treatment of pancreatic islet cell tumors in dogs. DESIGN: Retrospective study. ANIMALS: 17 dogs. PROCEDURE: Medical records were reviewed to obtain information regarding signalment, tumor stage and staging tests performed, number of streptozocin treatments, adverse effects, results of biochemical and hematologic monitoring during streptozocin treatment, tumor dimensions, duration of normoglycemia, and date of death, when applicable. Dogs were compared with a historical control group of 15 dogs treated surgically and medically. RESULTS: 58 treatments were administered to the 17 dogs. Only 1 dog developed azotemia. Serum alanine aminotransferase activity increased in some dogs but decreased when treatment was discontinued. Hematologic toxicoses were rare. Vomiting during administration was uncommon but occasionally severe. Two dogs developed diabetes mellitus after receiving 5 doses. Median duration of normoglycemia for 14 dogs with stage-II or -III insulinoma treated with streptozocin was 163 days (95% confidence interval, 16 to 309 days), which was not significantly different from that for the control dogs (90 days; 95% confidence interval, 0 to 426 days). Two dogs had rapid resolution of paraneoplastic peripheral neuropathy, and 2 others had measurable reductions in tumor size. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that streptozocin can be administered safely to dogs at a dosage of 500 mg/m2, IV, every 3 weeks when combined with a protocol for induction of diuresis and may be efficacious in the treatment of dogs with metastatic pancreatic islet cell tumors. 相似文献
10.
Flowers of 22 plant species grown in the Arava region of Israel were sampled at periodic intervals to study the seasonal abundance
ofFrankliniella occidentalis (Pergande) (Thysanoptera: Thripidae). Samples were collected from the most common cut-flower and vegetable plant species
in this area during 1997 and from pepper in 1996–1998. Western flower thrips (WFT) was detected on 19 of the plant species
surveyed, and it reproduced on numerous plant species. WFT counts peaked in late February–April and in October–December. The
peak density of WFT during March in our survey corresponded to the peak flowering of cut-flower plants (during spring) and
sweet pepper (during autumn). Thrips population was less abundant during autumn than in spring and was very low during summer.
The possible reasons for fluctuations in thrips densities are abiotic factors (temperature and relative humidity), and availability
of flowering plants. The high temperature (>40°C) and low humidity (∼20%) in summer caused a drastic reduction in WFT populations,
although some flowering plant species were available in this season. WFT population remained low until October, when adults
appeared in large numbers on flowering pepper. We assume that the thrips had survived the hottest months by aestivation and
migrated to the plants when air temperature decreased. In most samples from the cut-flower fields, 84.8% were adult WFT; only
during the period from the end of January to March, did the proportion of immature stages in the thrips population increase
to 31.6%. Females always outnumbered males (71% females). In pepper fields during the first cropping month the thrips population
included 96% adults; from November onwards, the proportions of adults and immatures were almost equal; and females outnumbered
males. Organic pepper fields were not infested with thrips because of the presence of the predatory bugOrius albidipennis (Fieber).
Contribution from the Agricultural Research Organization. No. 534/00, 2000 series.
http://www.phytoparasitica.org posting July 16, 2002. 相似文献